Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation

In December 2019, a new severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing coronavirus diseases 2019 (COVID-19) emerged in Wuhan, China. African countries see slower dynamic of COVID-19 cases and deaths. One of the assumptions that may explain this later emergence in Africa, and more...

Descripción completa

Detalles Bibliográficos
Autores principales: Gendrot, Mathieu, Andreani, Julien, Boxberger, Manon, Jardot, Priscilla, Fonta, Isabelle, Le Bideau, Marion, Duflot, Isabelle, Mosnier, Joel, Rolland, Clara, Bogreau, Hervé, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477610/
https://www.ncbi.nlm.nih.gov/pubmed/32916297
http://dx.doi.org/10.1016/j.tmaid.2020.101873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477610/
https://www.ncbi.nlm.nih.gov/pubmed/32916297
http://dx.doi.org/10.1016/j.tmaid.2020.101873

Ejemplares similares